Raymond James & Associates’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,631	Closed	-$201K	–	3943
2024 Q2	$201K	Sell	21,631 -19,811	-48%	-$184K	﹤0.01%	3568
2024 Q1	$411K	Buy	+41,442	New	+$411K	﹤0.01%	3163